Literature DB >> 23367436

Feasibility of multiplex quantum dot stain using primary antibodies from four distinct host animals.

Jonathan K Tran1, Elena N Hubbard, Todd H Stokes, Richard A Moffitt, May D Wang.   

Abstract

We discuss the feasibility of multiplex QD stain for four biomarkers and our progress in finding four suitable biomarkers from four different hosts. There is a demand for using more than three fluorescent probes on a single tissue sample for disease detection to offer a more reliable prediction of disease progression. We developed a protocol for targeting four biomarkers using four primary antibodies from four different animal hosts. We performed primary-secondary antibody binding assays on nitrocellulose paper and stained breast cancer microarray slides with known expression of ER, PR, and HER2. We identified the lack of a standard protocol and the limited supply of primary antibodies from hosts other than rabbit and mouse in the market as key challenges. The results show variable success in both assays, but indicate future potential for this protocol with more development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23367436      PMCID: PMC4983428          DOI: 10.1109/EMBC.2012.6347501

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  7 in total

1.  Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry.

Authors:  Yun Xing; Qaiser Chaudry; Christopher Shen; Koon Yin Kong; Haiyen E Zhau; Leland W Chung; John A Petros; Ruth M O'Regan; Maksym V Yezhelyev; Jonathan W Simons; May D Wang; Shuming Nie
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

Review 2.  ErbB family receptor inhibitors as therapeutic agents in breast cancer: current status and future clinical perspective.

Authors:  Ruchi Saxena; Anila Dwivedi
Journal:  Med Res Rev       Date:  2010-10-25       Impact factor: 12.944

3.  In vitro selection of RNA aptamer and specific targeting of ErbB2 in breast cancer cells.

Authors:  Mee Young Kim; Sunjoo Jeong
Journal:  Nucleic Acid Ther       Date:  2011-06       Impact factor: 5.486

4.  Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots.

Authors:  Jian Liu; Stephen K Lau; Vijay A Varma; Richard A Moffitt; Matthew Caldwell; Tao Liu; Andrew N Young; John A Petros; Adeboye O Osunkoya; Tracey Krogstad; Brian Leyland-Jones; May D Wang; Shuming Nie
Journal:  ACS Nano       Date:  2010-05-25       Impact factor: 15.881

Review 5.  Breast cancer statistics, 2011.

Authors:  Carol DeSantis; Rebecca Siegel; Priti Bandi; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2011-10-03       Impact factor: 508.702

6.  Simple quantification of multiplexed quantum dot staining in clinical tissue samples.

Authors:  Matthew L Caldwell; Richard A Moffitt; Jian Liu; R Mitchell Parry; Yachna Sharma; May D Wang
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2008

7.  The Potential Utility of Curcumin in the Treatment of HER-2-Overexpressed Breast Cancer: An In Vitro and In Vivo Comparison Study with Herceptin.

Authors:  Hung-Wen Lai; Su-Yu Chien; Shou-Jen Kuo; Ling-Ming Tseng; Hui-Yi Lin; Chin-Wen Chi; Dar-Ren Chen
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-06       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.